Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
ANGO [NASD]
AngioDynamics Inc.
Index- P/E143.80 EPS (ttm)0.10 Insider Own1.40% Shs Outstand35.42M Perf Week4.35%
Market Cap509.34M Forward P/E33.44 EPS next Y0.43 Insider Trans21.57% Shs Float34.98M Perf Month-10.24%
Income3.70M PEG9.59 EPS next Q0.11 Inst Own90.90% Short Float1.21% Perf Quarter-15.76%
Sales350.40M P/S1.45 EPS this Y90.00% Inst Trans0.02% Short Ratio2.82 Perf Half Y-5.70%
Book/sh15.28 P/B0.94 EPS next Y44.30% ROA0.50% Target Price18.56 Perf Year48.55%
Cash/sh0.26 P/C55.36 EPS next 5Y15.00% ROE0.70% 52W Range9.68 - 19.00 Perf YTD-16.20%
Dividend- P/FCF39.18 EPS past 5Y-15.40% ROI1.10% 52W High-27.11% Beta0.68
Dividend %- Quick Ratio1.30 Sales past 5Y15.50% Gross Margin50.60% 52W Low43.08% ATR0.57
Employees1330 Current Ratio2.20 Sales Q/Q8.10% Oper. Margin6.60% RSI (14)36.48 Volatility4.00% 3.91%
OptionableYes Debt/Eq0.26 EPS Q/Q566.70% Profit Margin1.10% Rel Volume0.29 Prev Close14.38
ShortableYes LT Debt/Eq0.25 EarningsApr 09 AMC Payout0.00% Avg Volume150.09K Price13.85
Recom2.50 SMA20-8.52% SMA50-11.41% SMA200-4.87% Volume33,920 Change-3.69%
09-Oct-12Reiterated Canaccord Genuity Hold $14 → $13.50
25-Jun-12Downgrade Canaccord Genuity Buy → Hold $16.50 → $14.50
15-Jul-11Upgrade Stifel Nicolaus Hold → Buy $16.50
15-Jul-11Upgrade Canaccord Genuity Hold → Buy $15 → $16.50
14-Jun-11Downgrade Wedbush Neutral → Underperform $14 → $12
08-Sep-10Reiterated Wedbush Neutral $17.50 → $14
04-Mar-10Initiated Wedbush Morgan Neutral $17.50
04-Sep-09Reiterated Caris & Company Above Average $13 → $15
17-Jul-09Reiterated Caris & Company Above Average $15 → $13
07-Jan-09Downgrade Caris & Company Buy → Above Average $20 → $15
13-Nov-08Initiated Stifel Nicolaus Hold
26-Sep-08Initiated Caris & Company Buy $20
11-Apr-08Reiterated Friedman Billings Mkt Perform $14 → $16
03-Apr-08Reiterated Friedman Billings Mkt Perform $16 → $14
07-Mar-08Downgrade Canaccord Adams Buy → Hold $25 → $16
13-Sep-07Reiterated Canaccord Adams Buy $23 → $25
23-Apr-07Upgrade Sun Trust Rbsn Humphrey Neutral → Buy $20
05-Apr-07Initiated Sun Trust Rbsn Humphrey Neutral
20-Mar-07Initiated Piper Jaffray Market Perform $24
15-Apr-14 01:04PM  ANGIODYNAMICS INC Financials EDGAR Online Financials
14-Apr-14 06:56AM  Weakness Seen in AngioDynamics (ANGO): Stock Tumbles 7.8% Zacks
11-Apr-14 10:16AM  AngioDynamics Delivering The Growth, Margins Next? at Seeking Alpha -7.75%
08:28AM  AngioDynamics Q3 Earnings Flat but Beat Ests Zacks
09-Apr-14 10:56PM  AngioDynamics' CEO Discusses F3Q2014 Results - Earnings Call Transcript at Seeking Alpha
05:07PM  Bed Bath & Beyond shares fall on outlook at MarketWatch
04:37PM  ANGIODYNAMICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit EDGAR Online
04:30PM  AngioDynamics Inc Earnings Call scheduled for 4:30 pm ET today CCBN
04:25PM  AngioDynamics, Inc. Discusses Q3 2014 Results (Webcast) at Seeking Alpha
04:24PM  ANGIODYNAMICS INC Files SEC form 10-Q, Quarterly Report EDGAR Online
04:19PM  AngioDynamics Inc Earnings Call scheduled for 4:30 pm ET today CCBN
04:01PM  AngioDynamics Reports Fiscal 2014 Third Quarter Financial Results GlobeNewswire
03:19PM  Notable companies reporting after market close at theflyonthewall.com
07:34AM  AngioDynamics Inc Earnings Call scheduled for 4:30 pm ET today CCBN
07:07AM  Q3 2014 AngioDynamics Inc Earnings Release - After Market Close CCBN
25-Mar-14 06:30AM  AngioDynamics to Report Fiscal 2014 Third Quarter Financial Results GlobeNewswire
20-Mar-14 06:30AM  AngioDynamics Awarded $74.9 Million in Case Against biolitec AG GlobeNewswire
18-Mar-14 05:26PM  Biolitec Ordered to Pay $74.9 Million to AngioDynamics at Bloomberg
14-Mar-14 11:00AM  AngioDynamics Raised to Hold Zacks
11:00AM  AngioDynamics Raised to Hold
13-Mar-14 02:22AM  AngioDynamics (ANGO) in Focus: Stock Moves 5.7% Higher Zacks
02:22AM  AngioDynamics (ANGO) in Focus: Stock Moves 5.7% Higher
12-Mar-14 12:02PM  Wednesday's Top Upgrades (and Downgrades) Motley Fool +5.74%
05:44AM  AngioDynamics upgraded to Outperform from Market Perform at Raymond James at theflyonthewall.com
05:44AM  AngioDynamics upgraded to Outperform from Market Perform at Raymond James
11-Mar-14 06:31AM  AngioDynamics announces FDA approval for its AngioVac cannula at theflyonthewall.com
06:31AM  AngioDynamics announces FDA approval for its AngioVac cannula
06:30AM  AngioDynamics Receives Expanded FDA Clearance for AngioVac GlobeNewswire
10-Mar-14 04:45PM  ANGIODYNAMICS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04:30PM  AngioDynamics Gets 3rd FDA Approval for BioFlo Zacks
04:30PM  AngioDynamics Gets 3rd FDA Approval for BioFlo
07-Mar-14 06:32AM  AngioDynamics granted FDA clearance for DuraMax dialysis catheter theflyonthewall.com
06:32AM  AngioDynamics granted FDA clearance for DuraMax dialysis catheter
06:30AM  AngioDynamics Receives FDA Clearance for DuraMax Dialysis Catheter With BioFlo Technology to Reduce Catheter-Related Thrombus GlobeNewswire
06-Mar-14 04:01PM  AngioDynamics Updates U.S. Tip Location Strategy GlobeNewswire
03-Mar-14 02:10PM  Cyberonics Upped to Buy Zacks
07:00AM  AngioDynamics to Present at the Barclays Global Healthcare Conference GlobeNewswire
25-Feb-14 08:00AM  Wider Q4 Loss, Poor Outlook at Volcano Corp. Zacks
21-Feb-14 02:00PM  Updated Research Report on Cepheid Zacks
06:04AM  Why Cynosure (CYNO) Has A Bright Short-Term Future? Zacks
14-Feb-14 02:43PM  Masimo Q4 Earnings Meet Ests Zacks
10-Feb-14 12:26PM  Thoratec Earnings Meet Ests but Fall Y/Y Zacks
05-Feb-14 02:10PM  Q1 Earnings Beat & Revs in Line at Hologic Zacks
03-Feb-14 11:57AM  Accuray Sees Narrower Loss, Hits 52-Week High Zacks
24-Jan-14 09:20AM  Intuitive Surgical Tops on Q4 Earnings & Revs Zacks
15-Jan-14 05:26PM  ANGIODYNAMICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
05:26PM  ANGIODYNAMICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
01:04PM  ANGIODYNAMICS INC Financials EDGAR Online Financials
01:04PM  ANGIODYNAMICS INC Financials
14-Jan-14 07:42PM  The Story Is Working For AngioDynamics at Seeking Alpha
07:42PM  The Story Is Working For AngioDynamics
06:53PM  AngioDynamics Wins Default Judgment in Biolitec Litigation at Bloomberg
06:53PM  AngioDynamics Wins Default Judgment in Biolitec Litigation
10-Jan-14 10:16AM  Keep a Close Watch on Synta Pharmaceuticals Corp., Raptor Pharmaceuticals Corp. and AngioDynamics, Inc. Today at Motley Fool
10:16AM  Keep a Close Watch on Synta Pharmaceuticals Corp., Raptor Pharmaceuticals Corp. and AngioDynamics, Inc. Today
09-Jan-14 09:00PM  AngioDynamics Management Discusses Q2 2014 Results - Earnings Call Transcript at Seeking Alpha
09:00PM  AngioDynamics Management Discusses Q2 2014 Results - Earnings Call Transcript
06:02PM  U.S./Canada daily earnings hits & misses Jan 9 - 1800 ET Reuters
06:02PM  U.S./Canada daily earnings hits & misses Jan 9 - 1800 ET
05:00PM  U.S./Canada daily earnings hits & misses Jan 9 - 1700 ET Reuters
04:25PM  Q2 2014 Angiodynamics Inc Earnings Conference call (Webcast) at Seeking Alpha
04:25PM  Q2 2014 Angiodynamics Inc Earnings Conference call (Webcast)
04:22PM  ANGIODYNAMICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit EDGAR Online
04:22PM  ANGIODYNAMICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
04:01PM  AngioDynamics Reports Fiscal 2014 Second Quarter Financial Results GlobeNewswire
04:01PM  AngioDynamics Reports Fiscal 2014 Second Quarter Financial Results
12:20PM  Whisper Number: How Will AngioDynamics Investors React to Earnings? at Wall St. Cheat Sheet
12:20PM  Whisper Number: How Will AngioDynamics Investors React to Earnings?
07:07AM  Q2 2014 AngioDynamics Earnings Release - After Market Close CCBN
07:07AM  Q2 2014 AngioDynamics Earnings Release - After Market Close
07-Jan-14 08:30AM  Masimo Reaches New 52-Week High Zacks
08:30AM  Masimo Reaches New 52-Week High
18-Dec-13 07:00AM  AngioDynamics to Present at 32nd Annual J.P. Morgan Healthcare Conference GlobeNewswire
07:00AM  AngioDynamics to Present at 32nd Annual J.P. Morgan Healthcare Conference
12-Dec-13 04:09PM  ANGIODYNAMICS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04:09PM  ANGIODYNAMICS INC Files SEC form 8-K, Change in Directors or Principal Officers
07:00AM  AngioDynamics to Report Fiscal 2014 Second Quarter Financial Results GlobeNewswire
07:00AM  AngioDynamics to Report Fiscal 2014 Second Quarter Financial Results
11-Dec-13 07:02AM  AngioDynamics appoints John Soto as Chief Commercial Officer at theflyonthewall.com
07:00AM  AngioDynamics Appoints John Soto Chief Commercial Officer GlobeNewswire
10-Dec-13 07:00AM  AngioDynamics Comments on New Reimbursement Rate for Hospital-Based Varicose Vein Ablations GlobeNewswire
06-Dec-13 02:42PM  AngioDynamics Turned The Corner, Solid Growth Ahead at Seeking Alpha
05-Dec-13 07:16AM  InPlay: AngioDynamics announces operational excellence program; expects to save $15 mln to $18 mln over the next three years Briefing.com
07:00AM  AngioDynamics Announces Operational Excellence Program GlobeNewswire
03-Dec-13 12:10PM  Accuray Reiterated at Neutral Zacks
02-Dec-13 12:10PM  Luminex Remains Neutral Zacks
27-Nov-13 03:45PM  TMO-LIFE Deal Gains Regulatory Nod Zacks
10:10AM  BSX' Promus PREMIER DES Gets FDA Nod Zacks
25-Nov-13 12:20PM  PetMed Slips to Neutral Zacks
22-Nov-13 04:55PM  A Trio of Stock Prospects in Medical Devices at Motley Fool
20-Nov-13 12:10PM  Teleflex Unveils New Product Line Zacks
06:30AM  AngioDynamics to Present at 25th Annual Piper Jaffray Healthcare Conference GlobeNewswire
05-Nov-13 03:54PM  ANGIODYNAMICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
04-Nov-13 06:30AM  AngioDynamics to Present at Upcoming Investor Conferences GlobeNewswire
29-Oct-13 06:30AM  InPlay: AngioDynamics achieves CE approval for AngioVac Briefing.com
06:30AM  AngioDynamics Achieves CE Approval for AngioVac GlobeNewswire
25-Oct-13 01:08PM  ANGIODYNAMICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
16-Oct-13 01:40PM  AngioDynamics Bags Major Deal Zacks
01:04PM  ANGIODYNAMICS INC Financials EDGAR Online Financials
15-Oct-13 10:30AM  ANGO Beats Q1 Earnings, Hits 52-Week High Zacks
AngioDynamics, Inc. designs, manufactures, and sells medical, surgical, and diagnostic devices. The company offers manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; and venous products, including laser system products used in endovascular laser procedures to treat superficial venous diseases, as well as sclerosing drugs that are used in the treatment of small uncomplicated varicose veins of the lower extremities. It also provides angiographic catheters and guidewires used during peripheral vascular interventional procedures; venous drainage cannula intended for use as a venous drainage cannula during extracorporeal bypass and cardiopulmonary bypass circuit intended for use in procedures requiring extracorporeal circulatory support; and drainage products that drain abscesses and other fluid pockets. In addition, the company offers thrombolytic catheters that are used to deliver thrombolytic agents; renal infusion products to deliver drugs directly to the kidneys in order to prevent and treat acute kidney injuries; micro access sets for minimally-invasive procedures; dialysis catheters that provide short and long-term vascular access for dialysis patients; and peripherally inserted central catheters, implantable ports, and central venous catheters. Further, it provides radiofrequency ablation products, soft tissue surgical ablation products, and microwave ablation products. The company markets and sells its products to interventional radiologists, interventional cardiologists, vascular surgeons, and interventional and surgical oncologists directly in the United States; and directly and through distributors internationally. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kapusta Matthew CSVP, Business DevelopmentApr 14Buy13.901,00013,90027,005Apr 16 02:14 PM
Greiner Charles RVP - Global FinanceNov 14Option Exercise13.184,37357,63627,501Nov 15 05:23 PM
Greiner Charles RVP - Global FinanceNov 14Sale15.464,37367,61123,128Nov 15 05:23 PM
Greiner Charles RVP - Global FinanceNov 13Sale15.402,39236,84223,128Nov 15 05:23 PM
BUCCI VINCENTDirectorOct 18Buy15.205,00075,99086,696Oct 21 12:03 PM
DONNELLY HOWARD WDirectorOct 17Option Exercise11.0020,000220,00035,850Oct 21 12:00 PM
DONNELLY HOWARD WDirectorOct 17Sale15.0620,000301,20015,850Oct 21 12:00 PM
Gould Kevin JDirectorJul 22Buy12.002,70032,40010,950Jul 23 09:36 AM
Greiner Charles RVP - Global FranchiseMay 09Sale10.381,49515,51823,221May 16 02:36 PM